adrc.wisc.edu
Dr. Sterling Johnson weighs in on new Alzheimer’s blood tests
Sterling Johnson, PhD, spoke with The New York Times about new blood biomarker tests used to predict a person’s risk of developing Alzheimer’s disease. The tests measure p-tau217, a blood-based biomar...